Method development (R&D)

Enhance method development with state-of-the-art techniques and processes.

Why is method development important?

Analytical method development is the strategic selection and optimization of analytical techniques tailored to quantify a designated attribute of a drug substance or product. This multifaceted exercise employs a systematic framework for assessing and choosing methodologies that exhibit:

  • Sensitivity: Designed with a low limit of detection to measure small amounts of analyte
  • Specificity: Highly specific for the analyte of interest, distinguishing it from other present materials
  • Accuracy:  Yields results that are close to the true value
  • Precision: Reproducible method that leads to consistent results
  • Robustness: Resilient to small variations leading to method consistency
  • Compliance with regulations: Meets the requirements of regulatory bodies such as the USFDA or EMA

In addition to these criteria, the method should also be efficient and cost-effective.

Understanding our method development capabilities

We employ state-of-the-art techniques throughout our method development processes to ensure precise measurement of various critical quality attributes (CQA).

These methods encompass various types of analyses including:

  • Product variants
  • Content
  • Excipient
  • Process related impurities

For assessing defined attributes we utilize the following methods:

  • Identity

    • Isoform patterns by cIEF, CE-IEF

    • High-performance liquid chromatography (HPLC)
  •  Structure
    • Primary structure
      • Intact or reduced mass analysis
      • Peptide mapping
    • Higher-order structure
      • Circular dichroism and
      • Intrinsic flourescence assays
      • Differential scanning calorimetry (DSC)
      • Disulphide bond analysis
  • Quantity

    • Total protein content

    • UV absorbance

  • Impurity

    • HCP, HCD by RT-PCR

    • Aggregates by SE-HPLC or CE

    • Cell substrate impurities

    • Enzyme-linked immunosorbent assay (ELISA)

    • Reverse transcription-polymerase chain reaction (RT-PCR)

    • Charge variants by cIEF
  • Biological Activity

    • Cell based assay

    • Binding assay (Octet® surface plasmon resonance (SPR), and ELISA assays)

  • Microbial testing

    • Microbiological tests (sterility etc.)

    • Endotoxin

    • Sterility testing

      • Membrane filtration

      • Direct Inoculation

Why partner with Enzene for method development?

We are a CDMO and biosimilar developer driven by the vision of positively impacting the global healthcare landscape by bringing trusted and affordable medicines to market at speed.

Committed to progression, our CDMO capabilities are designed to support you at every stage of your development and manufacturing journey. Along with our proprietary continuous bioprocess manufacturing platform, EnzeneX™, we can provide everything you need in a partner.

Through a passionately progressive approach, our cutting-edge services and method development capabilities are designed to cater to your project’s every need.

 

Join the revolution

Fueled by our continuous innovation and armed with EnzeneX™, our fully-integrated CDMO solutions and our biosimilars pipeline are designed to help bring your biologics innovations to life.